Introduction Pancreatic ductal adenocarcinoma (PDA), or pancreatic cancer, is a devastating exogenous pancreatic disease that ranks the fourth leading cause of cancer mortality and is projected to be the second leading cause of death by 2030 in the United States (Rahib et al., 2014
Benefits of GLP-1 Drugs GLP-1 drugs are FDA-approved as a treatment for type 2 diabetes and as a weight-loss tool for those with obesity, as they have been demonstrated to be effective treatments for both conditions
For most people, the weekly convenience of tirzepatide is a significant practical advantage that directly translates to better adherence over months of treatment
But medications leading to so much weight loss may be needed for people with severe obesity (a BMI of 35 or more) or the 10% of patients who dont respond to GLP-1 medications and need something more powerful, Azar said
Serious Risks and Safety Monitoring As with other medicines affecting GLP-1 pathways, researchers are monitoring potential risks such as pancreatitis and gallbladder-related conditions